Streetbeat News

Stock Prices

ERJ

Embraer SA (NYSE:ERJ) reported Q2 FY23 revenue of $1.292 billion, a 27% Y/Y increase, beating the consensus of $1.162 billion. The company delivered 47 jets in Q2, a 47% Y/Y increase, and reaffirmed its FY23 outlook. However, ERJ shares are trading lower by 4.55% at $14.28.

Portfolio Pulse from Lekha Gupta

August 14, 2023 | 1:59 pm

HRYU

Shares of Hanryu Holdings were halted on a circuit breaker to the upside, with the stock now up by 37.9%.

Portfolio Pulse from Happy Mohamed

August 14, 2023 | 1:59 pm

BTAI

MNDY

ZYNE

U.S. stocks traded mostly lower with the Dow Jones falling around 50 points. Monday.com Ltd reported better-than-expected earnings for its second quarter and raised its 2023 revenue guidance. Zynerba Pharmaceuticals, Taysha Gene Therapies, and TMC the metals company saw their shares rise significantly. BioXcel Therapeutics, Hawaiian Electric Industries, and AMC Entertainment Holdings saw their shares drop significantly.

Portfolio Pulse from Lisa Levin

August 14, 2023 | 1:57 pm

TSHA

Shares of Taysha Gene Therapies have resumed trading.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 1:53 pm

VCIG

Trading of VCI Global Limited shares has resumed.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 1:50 pm

TSHA

Taysha Gene Therapies' stock (TSHA) has surged by 139.5%, triggering a circuit breaker to the upside.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 1:48 pm

AAP

Traders are circulating chatter about potential activist activity from Gordon Haskett in Advance Auto Parts (AAP).

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 1:48 pm

AGNPF

ATAI

PSIL

The American Psychedelic Practitioners Association and BrainFutures have published the first-ever professional practice guidelines for psychedelic-assisted therapy. Algernon NeuroScience, a subsidiary of Algernon Pharmaceuticals, has finalized its clinical trial design for a phase 2 DMT stroke study. Atai Life Sciences, MindMed, and COMPASS Pathways have reported their Q2 2023 financial results. AdvisorShares Psychedelics ETF has seen a decrease in its weekly performance.

Portfolio Pulse from Lara Goldstein

August 14, 2023 | 1:47 pm

MPC

A significant bearish stance has been taken on Marathon Petroleum (NYSE:MPC) by a large investor, as indicated by unusual options activity. The sentiment among these big-money traders is split between 40% bullish and 60% bearish. The whales have been targeting a price range from $115.0 to $150.0 for Marathon Petroleum over the last 3 months. The current price of MPC is $149.12, down by 0.42%. Analysts from Wells Fargo, RBC Capital, Barclays, Raymond James, and Morgan Stanley have maintained their ratings on MPC, with price targets ranging from $140 to $165.

Portfolio Pulse from Benzinga Insights

August 14, 2023 | 1:46 pm

BONEUSD

BTCUSD

ETHUSD

KAVAUSD

STXUSD

Bitcoin and Ethereum traded slightly lower, with Bitcoin falling below the $29,400 level and Ethereum trading below the $1,850 mark. The global crypto market cap fell to $1.17 trillion, recording a 24-hour decline of 0.2%. Hedera was the top gainer over the prior 24 hours, while Bone ShibaSwap turned out to be the biggest loser.

Portfolio Pulse from Lisa Levin

August 14, 2023 | 1:45 pm